XARMONTRA

Pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia and dermatological diseases and disorders; pharmaceutical preparations for the treatment of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders and hormonal diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines; pharmaceutical preparations for the treatment of muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders; sleep disorders, urological disorders; antidepressants